Dialysis amyloidosis: Clinical aspects and therapeutic approach

Nephrology Dialysis Transplantation

Volumn 11, Issue SUPPL. 3, 1996, Pages 102-105

  Brancaccio, D ^a,b   Cozzolino, M ^a   Gallieni, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b III Clinica Neurologica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN;

AMYLOIDOSIS; CLINICAL FEATURE; CONFERENCE PAPER; DIALYSIS; HUMAN; PRIORITY JOURNAL;

EID: 0029766519     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.supp3.102     Document Type: Conference Paper

References (22)

1. Floege J, Schaffer J, Koch KM, Shaldon S. Dialysis related amyloidosis: a disease of chronic retention and inflammation? Kidney Int 1992; 42 (suppl. 38): S78-S85
2. 2-microglobulin: a new form of amyloid protein associated with chronic hemodialysis. Kidney Int 1986; 30: 385-390
3. Kuntz D, Naveau B, Bardin T, Drucke T, Treves R, Dryll A. Destructive spondylarthropathy in hemodialyzed patients - a new syndrome. Arthritis Rheum 1984; 27: 369-375
4. 2-microglobulin amyloid deposition in the vertebral column. Kidney Int 1992; 41: 1646-1652
5. van Ypersele de Strihou C, Jadoul M, Malghem J, Maldague B, Jamart J. Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. Kidney Int 1991; 39: 1012-1019
6. Gielen JL, van Holsbeek MT, Hauglustaine D et al. Growing bone cysts in long term hemodialysis. Skeletal Radiol 1990; 19: 43-49
7. Bardin T, Bellini F, Laredo JD. Radiological evaluation of Beta-2 microglobulin amyloidosis. In: Gejyo F, Brancaccio D, Bardin T. Dialysis Amyloidosis. Milan: Wichtig, 1989: 91-100
8. Hawkins PN, Myers MJ, Lavender JP, Pepys MB. Diagnostic radionuclide imaging of amyloid: biological targeting by circulating human serum amyloid P component. Lancet 1988; 1: 1413-1418
9. Floege J, Nonnast-Daniel B, Gielow P et al. Specific imaging of dialysis related amyloid deposits using ml-j32-microglobu,lin. Nephron 1989; 51: 444-447
10. Brancaccio D, Ghiggeri GM, Braidotti P et al. Deposition of kappa and lambda light chains in amyloid filaments of dialysis-related amyloidosis. J Am Soc Nephrol 1995; 6: 1262-1270
11. Maeda K, Shinzato T, Ota T et al. Beta-2-microglobulin generation rate and clearance rate in maintenance hemodialysis patients. Nephron 1990; 56: 118-125
12. 2m kinetics in maintenance hemodialysis: a comparison of conventional and high-flux dialyzers and the effect of dialyzer reuse. Am J Kidney Dis 1989; 5: 390-395
13. 2-microglobulin deposition rate in uremic patients on hemodialysis using a mathematical kinetic model. Kidney Int 1995; 47: 1453-1457
14. 2-microglobulin: the constant chain of HLA-antigens. Eur J Clin Invest 1980; 10: 293-300
15. 2-microglobulin kinetics in end-stage renal failure. Kidney Int 1991; 39: 909-919
16. 2-microglobulin in patients undergoing hemodialysis and in normal subjects. J Lab Clin Med 1991; 118: 153-165
17. 2m amyloidosis in long-term dialysis patients. Am J Nephrol 1989; 9: 177-183
18. 2m amyloidosis in chronic renal failure. N Engl J Med 1990; 323: 1070-1071
19. 2m amyloidosis in a patient treated exclusively by CAPD. Can Med Assoc J 1988; 139: 753-755
20. Brunner FP, Brynger H, Ehrich JHH et al. Case control study on dialysis arthropathy: the influence of two different dialysis membranes: data from the EDTA Registry. Nephrol Dial Transplant 1990; 5: 432-436
21. Chanard J, Bindi P, Lavaud S, Toupance O, Maheut H, Lacour F. Carpal tunnel syndrome and type of dialysis membrane. Br Med J 1989; 298: 867-868
22. Miura Y, Ishiyama T, Inomata A. Radiolucent bone cysts and the type of dialysis used in patients undergoing long-term hemodialysis. Nephron 1992; 60: 268-273